Clinical outcomes are complex and often involve multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological activation.
The platform can help to match the needs of a team of authoritative experts at home and abroad, providing accurate diagnosis and treatment programs. Individualised treatment programs for the treatment and management of cerebral venous thrombosis are often included in drug therapy, rehabilitation interventions, and regular follow-up to multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, according to timely adjustments to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the formation of cerebrovascular thrombosis. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.